The Lys234Arg Substitution in the Enzyme SHV-72 Is a Determinant for Resistance to Clavulanic Acid Inhibition

Antimicrobial Agents and Chemotherapy
2008.0

Abstract

The new beta-lactamase SHV-72 was isolated from clinical Klebsiella pneumoniae INSRA1229, which exhibited the unusual association of resistance to the amoxicillin-clavulanic acid combination (MIC, 64 microg/ml) and susceptibility to cephalosporins, aztreonam, and imipenem. SHV-72 (pI 7.6) harbored the three amino acid substitutions Ile8Phe, Ala146Val, and Lys234Arg. SHV-72 had high catalytic efficiency against penicillins (k(cat)/K(m), 35 to 287 microM(-1) x s(-1)) and no activity against oxyimino beta-lactams. The concentration of clavulanic acid necessary to inhibit the enzyme activity by 50% was 10-fold higher for SHV-72 than for SHV-1. Molecular-dynamics simulation suggested that the Lys234Arg substitution in SHV-72 stabilized an atypical conformation of the Ser130 side chain, which moved the O gamma atom of Ser130 around 3.5 A away from the key O gamma atom of the reactive serine (Ser70). This movement may therefore decrease the susceptibility to clavulanic acid by preventing cross-linking between Ser130 and Ser70.

Knowledge Graph

Similar Paper

The Lys234Arg Substitution in the Enzyme SHV-72 Is a Determinant for Resistance to Clavulanic Acid Inhibition
Antimicrobial Agents and Chemotherapy 2008.0
Design and Exploration of Novel Boronic Acid Inhibitors Reveals Important Interactions with a Clavulanic Acid-Resistant Sulfhydryl-Variable (SHV) β-Lactamase
Journal of Medicinal Chemistry 2013.0
Biochemical Study of a New Inhibitor-Resistant β-Lactamase, SHV-84, Produced by a Clinical Escherichia coli Strain
Antimicrobial Agents and Chemotherapy 2010.0
Molecular and Biochemical Characterization of SHV-56, a Novel Inhibitor-Resistant β-Lactamase fromKlebsiella pneumoniae
Antimicrobial Agents and Chemotherapy 2008.0
Biochemical Characterization of SHV-55, an Extended-Spectrum Class A β-Lactamase from Klebsiella pneumoniae
Antimicrobial Agents and Chemotherapy 2008.0
Substrate Selectivity and a Novel Role in Inhibitor Discrimination by Residue 237 in the KPC-2 β-Lactamase
Antimicrobial Agents and Chemotherapy 2010.0
Homology modeling and docking study of recent SHV type β-lactamses with traditional and novel inhibitors: an in silico approach to combat problem of multiple drug resistance in various infections
Medicinal Chemistry Research 2012.0
New Variant of CTX-M-Type Extended-Spectrum β-Lactamases, CTX-M-71, with a Gly238Cys Substitution in a K lebsiella pneumoniae Isolate from Bulgaria
Antimicrobial Agents and Chemotherapy 2009.0
Clavulanic Acid: a Beta-Lactamase-Inhibiting Beta-Lactam from <i>Streptomyces clavuligerus</i>
Antimicrobial Agents and Chemotherapy 1977.0
Comparative Biochemical and Computational Study of the Role of Naturally Occurring Mutations at Ambler Positions 104 and 170 in GES β-Lactamases
Antimicrobial Agents and Chemotherapy 2010.0